May 17, 2005 (San Francisco) - Patients with hypertension and high ambulatory plasma renin levels are at greater risk of myocardial infarction and revascularization procedures than those with low ...
VANCOUVER, B.C.—High plasma renin activity (PRA) is associated with adverse renal outcomes in patients with coronary artery disease (CAD), according to study findings presented at the World Congress ...
Aliskiren is an orally active, nonpeptide, potent direct renin inhibitor that decreases plasma renin activity (PRA) and inhibits the conversion of angiotensinogen to angiotensin I. Unlike ACE ...